Paper475374
Human fibroblast interferon for clinical trials: production, partial purification, and characterization.
Billiau A and 7 others. Antimicrob Agents Chemother, 1979. Cited by 51 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Human fibroblast interferon for clinical trials: production, partial purification, and characterization. Papers, record 475374. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/475374
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human fibroblast interferon for clinical trials: production, partial purification, and characterization.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblasts | Major topic |
| Interferons | Major topic |
| Cells, Cultured | |
| Diploidy | |
| Humans | |
| Immunoelectrophoresis |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26,729 | Large-scale production of human leukocyte interferon containing 10(8) units per ml. | J Gen Virol | 1978 | https://conductscience.org/library/papers/26729 | PubMed |
| 2 | 82,514 | Uptake and degradation of alpha2-macroglobulin-protease complexes in human cells in culture. | Exp Cell Res | 1978 | https://conductscience.org/library/papers/82514 | PubMed |
| 3 | 71,999 | Demonstration of alpha2-macroglobulin in cultured fibroblasts, using crossed immunoelectrophoresis. | Exp Cell Res | 1977 | https://conductscience.org/library/papers/71999 | PubMed |
| 4 | 96,117 | Biochemical and immunological characterization of human opsonic alpha2SB glycoprotein: its identity with cold-insoluble globulin. | J Biol Chem | 1978 | https://conductscience.org/library/papers/96117 | PubMed |
| 5 | 342,973 | Purification of mouse interferon by sequential affinity chromatography on poly(U)--and antibody--agarose columns. | Nature | 1978 | https://conductscience.org/library/papers/342973 | PubMed |
| 6 | 291,364 | Transformation-sensitive cell surface protein: isolation, characterization, and role in cellular morphology and adhesion. | Ann N Y Acad Sci | 1978 | https://conductscience.org/library/papers/291364 | PubMed |
| 7 | 649,623 | The impossibility of defining unequivocally the antiviral activity of human fibroblast interferon in terms of a human leukocyte interferon standard. | J Biol Stand | 1978 | https://conductscience.org/library/papers/649623 | PubMed |
| 8 | 883,813 | Human interferon: mass production in a newly established cell line, MG-63. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/883813 | PubMed |
| 9 | 1,036,458 | Purification of interferon by adsorption chromatography on controlled pore glass. | J Gen Virol | 1976 | https://conductscience.org/library/papers/1036458 | PubMed |
| 10 | 4,360,630 | Mass production of human interferon in diploid cells stimulated by poly-I:C. | J Gen Virol | 1973 | https://conductscience.org/library/papers/4360630 | PubMed |
| 11 | 239,056 | Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons. | J Immunol | 1975 | https://conductscience.org/library/papers/239056 | PubMed |
| 12 | 53,841 | Multiple active sites on human interferons. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/53841 | PubMed |
| 13 | 4,471,020 | Mass production of human interferon in diploid cells. | In Vitro Monogr | 1974 | https://conductscience.org/library/papers/4471020 | PubMed |
| 14 | 180,244 | Human fibroblast and leukocyte interferons show different dose-response curves in assay of cell protection. | J Gen Virol | 1976 | https://conductscience.org/library/papers/180244 | PubMed |
| 15 | 164,521 | Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons. | J Gen Virol | 1975 | https://conductscience.org/library/papers/164521 | PubMed |
| 16 | 4,670,440 | Production of high-titered interferon in cultures of human diploid cells. | Antimicrob Agents Chemother | 1972 | https://conductscience.org/library/papers/4670440 | PubMed |
| 17 | 1,061,154 | Interferon: purification and initial characterization from human diploid cells. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/1061154 | PubMed |
| 18 | 1,185,850 | Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography. | J Virol | 1975 | https://conductscience.org/library/papers/1185850 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,140,938 | Inhibition of renal fibrosis with a human CXCL9-derived glycosaminoglycan-binding peptide. | Clin Transl Immunology | 2022 | https://conductscience.org/library/papers/35140938 | PubMed |
| 33,563,543 | Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity. | Cytokine Growth Factor Rev | 2021 | https://conductscience.org/library/papers/33563543 | PubMed |
| 32,694,927 | Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case. | Mediators Inflamm | 2020 | https://conductscience.org/library/papers/32694927 | PubMed |
| 6,400,034 | The clinical application of fibroblast interferon--an overview. | Med Oncol Tumor Pharmacother | 1984 | https://conductscience.org/library/papers/6400034 | PubMed |
| 6,167,863 | Comparative antiviral efficiency of leukocyte and bacterially produced human alpha-interferon in rhesus monkeys. | Nature | 1981 | https://conductscience.org/library/papers/6167863 | PubMed |
| 6,166,278 | Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice. | Arch Virol | 1981 | https://conductscience.org/library/papers/6166278 | PubMed |
| 6,163,417 | Interferon therapy: pharmacokinetic and pharmacological aspects. | Arch Virol | 1981 | https://conductscience.org/library/papers/6163417 | PubMed |
| 2,379,114 | The induction and characterization of natural porcine interferons alpha and beta. | Can J Vet Res | 1990 | https://conductscience.org/library/papers/2379114 | PubMed |
| 475,375 | Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/475375 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FN1 | 2,335 | PubTator's text mining | https://conductscience.org/library/genes/2335 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/475374
GET https://conductscience.org/api/papers/v1/475374/authors